Bengaluru-based biopharma firm Biocon on Thursday reported a consolidated net profit of Rs 25.1 crore in the third quarter of the financial year 2024-25 (Q3FY25). During the same period in the ...

Q3 2025 Management View CEO David Cataford highlighted that despite operational challenges, the company produced over 3.6 million tonnes and sold nearly 3.3 million tonnes during the quarter. He noted ...

L&T stock price has remained weak in the past one year. While L&T shares are down 3% in one month, they have fallen 8% in six months and over 4% in one year.

Q4 2024 Management View CEO Jim Fitterling highlighted a 2% year-over-year decline in net sales to $10.4 billion, citing pricing pressures across all segments. Operating EBITDA was flat at $1.2 ...

Kalyan Jewellers on Thursday posted a 21.23 per cent jump in consolidated net profit to Rs 218.68 crore for the third quarter of the 2024-25 fiscal on robust sales.